Skip to main content

A Double-blind, Randomized, Placebo-controlled Trial of Adjunctive Ganaxolone Treatment in Children and Young Adults with Cyclin-dependent Kinase-like 5 (CDKL5) Deficiency Disorder (CDD) Followed by Long-term Open-label Treatment

Clinical Trial Grant
Duke Scholars

Administered By

Pediatrics, Neurology

Awarded By

Marinus Pharmaceuticals, Inc.

Start Date

October 30, 2018

End Date

September 22, 2020
 

Administered By

Pediatrics, Neurology

Awarded By

Marinus Pharmaceuticals, Inc.

Start Date

October 30, 2018

End Date

September 22, 2020